Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Breast Neoplasms, Male × Gonadotropin-Releasing Hormone × 1 year × Clear all

Sponsor

Conditions

Prostatic Neoplasms 21 Breast Neoplasms 13 Neoplasms by Site 2 Neoplasms 2 Neoplasm Metastasis 2 Breast Diseases 2 Stage II Prostate Adenocarcinoma 1 Skin Diseases 1 Salivary Gland Neoplasms 1 Prostatic Neoplasms, Castration-Resistant 1 Prostate Cancer Metastatic 1 Ovarian Neoplasms 1 Oligometastatic Prostate Carcinoma 1 Metastatic Neuroendocrine Prostate Cancer 1 Metastatic Castration-resistant Prostate Cancer 1 Metastatic Castration-Resistant Prostate Cancer 1 Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer 1 Endometrial Neoplasms 1 Dementia 1 Cognitive Dysfunction 1 Anatomic Stage III Breast Cancer AJCC v8 1

Interventions

Taxes 4 Paclitaxel 3 Cyclophosphamide 3 exemestane 2 Tamoxifen 2 Leuprolide 2 Letrozole 2 Immunotherapy 2 Goserelin 2 Doxorubicin 2 Anastrozole 2 trastuzumab biosimilar HLX02 1 romidepsin 1 ribociclib 1 pegfilgrastim 1 entinostat 1 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1 abemaciclib 1 Vitamins 1 Trastuzumab 1 Psychiatric Rehabilitation 1 PF-05280014 1 Ontruzant 1 Omeprazole 1 Ogivri 1 Neoadjuvant Therapy 1 Mental Status and Dementia Tests 1 Lapatinib 1 Indomethacin 1 Immunoglobulin G 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡